Loading clinical trials...
Loading clinical trials...
This feasibility study tests if patients find incremental HD acceptable, whether they tolerate the treatment as planned and to evaluate its safety. Over a period of 18-months, 20 participants will be ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hull University Teaching Hospitals NHS Trust
NCT06001827 · Chronic Kidney Diseases, End Stage Renal Disease, and more
NCT06169514 · Hypoxemia, Morality, and more
NCT03778944 · Renal Failure Chronic, Transplant;Failure,Kidney, and more
NCT06056102 · Kidney Transplant, Kidney Failure, and more
NCT06297343 · Renal Failure
Hull University Teaching Hospitals NHS Trust
Hull, East Yorkshire
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions